Boulder Medical Center Urologists are part of a select group of physicians participating in a clinical trial comparing Aquablation® (waterjet) therapy for the treatment of prostate cancer to traditional radical prostatectomy.  The trial is the first of its kind to use the minimally invasive robotically-controlled waterjet surgery to remove cancer tissue compared to traditional surgery that removes the entire prostate.